CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.(CELZ)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CELZ is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.2m in revenue and is scored on the micro-cap board instead. Top institutional holders of CELZ by reported 13-F value include Hudson Bay Capital Management, Anson Funds Management, ARMISTICE CAPITAL, based on the most recent SEC filings. CELZ trades on the Nasdaq exchange and files with the SEC under CIK 1187953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CELZ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. directly from SEC EDGAR.

Revenue

$0.00

Net Income

$-1.5M

CELZ key financials by period

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$6.0K$-6.0M—
FY 202410-K$11.0K$-5.5M—
FY 202310-K$9.0K$-5.3M—
FY 202210-K$88.6K$-10.1M—
FY 202110-K$87.8K$19.2M—
FY 202010-K$164.5K$-36.3M—

Institutions holding CELZ

Institutional investors reporting a position in CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. on SEC Form 13F.
InstitutionSharesValueReported
Hudson Bay Capital Management135,170$196.0K2026-06-30
Anson Funds Management105,549$153.0K2026-06-30
ARMISTICE CAPITAL42,000$60.9K2026-06-30
XTX Topco Ltd26,559$38.5K2026-06-30
GEODE CAPITAL MANAGEMENT25,799$37.4K2026-06-30
VANGUARD CAPITAL MANAGEMENT20,350$29.5K2026-06-30
VANGUARD FIDUCIARY5,518$8.0K2026-06-30
Tower Research Capital (TRC)4,853$7.0K2026-06-30
Global Retirement Partners4,118$6.0K2026-06-30
UBS Group AG2,061$3.0K2026-06-30
SEC EDGAR: CIK 1187953 →
CELZ

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$0

Net Income

Q2 2026
EDGAR

$-1.51M

EPS (Diluted)

Q2 2026
EDGAR

$-0.41

ROIC

Q2 2026
EDGAR

-72.2%

Top Institutional Holders

as of Q2 2026
$540.3K total
Hudson Bay Capital Management LP
$196.0KNew
Anson Funds Management LP
$153.0KNew
ARMISTICE CAPITAL, LLC
$60.9KNew
XTX Topco Ltd
$38.5K+86.2%
GEODE CAPITAL MANAGEMENT, LLC
$37.4K-32.6%
VANGUARD CAPITAL MANAGEMENT LLC
$29.5K0.0%
VANGUARD FIDUCIARY TRUST CO
$8.0K0.0%
Tower Research Capital LLC (TRC)
$7.0K+132.0%
Global Retirement Partners, LLC
$6.0KNew
UBS Group AG
$3.0KNew

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…